Search Within

Sheng Feng Cai

Formats
  1. Journal Article (26)
  2. Meeting Abstract (20)
  3. Review (3)
  4. Editorial (2)
  5. Research Letter (1)
Groups
  1. Adult Leukemia (52)
  2. Center for Hematologic Malignancies (52)
  3. Department of Medicine (52)
  4. Hematologic Malignancies, Division of (52)
  5. Hematology-Oncology Fellows (52)
  6. GSK Faculty (36)

More Groups

People
  1. Ross Levine (34)
  2. Eytan Stein (22)
  3. Christopher Famulare (19)
  4. Martin Tallman (19)
  5. Aaron Goldberg (17)
  6. Wenbin Xiao (17)

More People

Years
  1. 2025 (6)
  2. 2024 (8)
  3. 2023 (10)
  4. 2022 (4)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Blood (20)
  2. Blood Advances (5)
  3. Cancer Discovery (4)
  4. American Journal of Hematology (2)
  5. Cancer Cell (2)
  6. Nature (2)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. American Association for Cancer Research (6)
  3. Cell Press (5)
  4. Elsevier Inc. (2)
  5. John Wiley & Sons, Inc. (2)
  6. Nature Publishing Group (2)

More Publishers

Results (52)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RAS mutations are independently associated with decreased overall survival and event-free survival in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Famulare, C.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z. D.; Menghrajani, K.; Glass, J. L.; Taylor, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Genetic and epigenetic determinants of AML pathogenesis
    Review

    Cai, S. F.; Levine, R. L.
    Seminars in Hematology (2019)

    Fulltext@MSK | Save
  • Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
    Journal Article

    Xiao, W.; Yabe, M.; Offin, M.; Khattar, P.; Baik, J.; Daley, R. J.; Pappacena, J. J.; Roshal, M.; Zhang, Y.; Tallman, M. S.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • HOXA9 reprograms the enhancer landscape to promote leukemogenesis
    Journal Article

    Sun, Y.; Zhou, B.; Mao, F.; Xu, J.; Miao, H.; Zou, Z.; Phuc Khoa, L. T.; Jang, Y.; Cai, S.; Witkin, M.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML
    Journal Article

    Cusan, M.; Cai, S. F.; Mohammad, H. P.; Krivtsov, A.; Chramiec, A.; Loizou, E.; Witkin, M. D.; Smitheman, K. N.; Tenen, D. G.; Ye, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • LSD1 inhibition exerts its anti-leukemic effect by recommissioning PU.1-and C/Ebpα-dependent enhancers in AML
    Meeting Abstract

    Cusan, M.; Cai, S.; Mohammad, H. P.; Krivtsov, A. V.; Chramiec, A.; Loizou, E.; Tenen, D. G.; Ye, M.; Will, B.; Steidl, U. G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • An epigenetic regulator screen identifies novel targets that sensitize MLL-rearranged leukemia to DOT1L inhibition
    Meeting Abstract

    Chen, C. W. D.; Delaney, C.; Xu, H.; Koche, R.; Goizueta, A. L.; Hoshii, T.; Cusan, M.; Chabon, J.; Valerio, D. G.; Kuehn, M.; more...
    Blood (2016)

    Fulltext@MSK | Save